Valuation Ironwood Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 23:00:00 23/10/2026 +03			5-day change	1st Jan Change
3.460 ^USD	-3.08%		-1.14%	+2.67%

10-16	Ironwood Pharmaceuticals, Inc. Announces CEO Changes, Effective January 1, 2027	CI
10-16	Ironwood Pharmaceuticals, Inc. Appoints Tammi Gaskins as Member of the Board of Directors, Effective January 1, 2027	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,908	1,901	1,786	708.9	548.2	571.7	-	-
Change	-	-0.4%	-6.02%	-60.31%	-22.67%	4.29%	-	-
Enterprise Value (EV)	1,742	1,641	1,786	708.9	548.2	571.7	571.7	571.7
Change	-	-5.83%	8.87%	-60.31%	-22.67%	4.29%	0%	0%
P/E	3.63x	12.9x	-1.77x	443x	22.5x	2.83x	2.63x	2.42x
PBR	3.12x	3.54x	-	-	-	-	-	-
PEG	-	-0.2x	0x	-4x	0x	0x	0.34x	0.28x
Capitalization / Revenue	4.61x	4.63x	4.03x	2.02x	1.85x	1.21x	1.16x	1.14x
EV / Revenue	0x	0x	0x	0x	0x	1.21x	1.16x	1.14x
EV / EBITDA	0x	0x	-0x	0x	0x	1.71x	1.66x	1.59x
EV / EBIT	0x	0x	-0x	0x	0x	1.8x	1.86x	1.81x
EV / FCF	0x	0x	0x	0x	0x	2.74x	2.13x	2.06x
FCF Yield	13.7%	14.4%	10.3%	14.6%	23.2%	36.5%	47%	48.6%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	3.21	0.96	-6.45	0.01	0.15	1.223	1.317	1.43
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	413.8	410.6	442.7	351.4	296.2	471.4	494	500.5
EBITDA ¹	233.7	251.8	-884.8	100.6	138.1	334.2	343.4	358.8
EBIT ¹	232.2	250.3	-945.4	94.85	98.5	316.8	307.6	315.5
Net income ¹	528.4	175.1	-1,002	1.813	24.02	203.3	219.9	240.7
Net Debt	-165.9	-260	-	-	-	-	-	-
Reference price ²	11.660	12.390	11.440	4.430	3.370	3.460	3.460	3.460
Nbr of stocks (in thousands)	163,650	153,395	156,129	160,028	162,679	165,240	-	-
Announcement Date	2/17/22 A	2/16/23 A	2/15/24 A	2/27/25 A	2/25/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IRONWOOD PHARMACEUTICALS, INC.	2.83x	-	-	-	572M
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	26.83x	7.04x	18.69x	2.12%	400.42B
Weighted average by Cap.	35.22x	8.29x	20.39x	1.8%